UA113991C2 - 1- (1-methyl-1H-pyrazol-4-yl) -N - ((1R, 5S, 7S) -9-methyl-3-oxa-9-azabicyclo [3.3.1] -NONAN-7-yl) -1H-INDOL-3-CARBOXAMID AS A 5-HT3 RECEPTOR ANTAGONIST - Google Patents
1- (1-methyl-1H-pyrazol-4-yl) -N - ((1R, 5S, 7S) -9-methyl-3-oxa-9-azabicyclo [3.3.1] -NONAN-7-yl) -1H-INDOL-3-CARBOXAMID AS A 5-HT3 RECEPTOR ANTAGONISTInfo
- Publication number
- UA113991C2 UA113991C2 UAA201500605A UAA201500605A UA113991C2 UA 113991 C2 UA113991 C2 UA 113991C2 UA A201500605 A UAA201500605 A UA A201500605A UA A201500605 A UAA201500605 A UA A201500605A UA 113991 C2 UA113991 C2 UA 113991C2
- Authority
- UA
- Ukraine
- Prior art keywords
- methyl
- nonan
- azabicyclo
- pyrazol
- oxa
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Даний винахід забезпечує антагоністи 5-НТЗ рецептора формули (І):, (I)зокрема 1-(1-метил-1H-піразол-4-іл)-N-((1R,5S,7S)-9-метил-3-окса-9-азабіцикло[3.3.1]-нонан-7-іл)-1H-індол-3-карбоксамід, для лікування захворювань, таких як блювання, біль, зловживання лікарськими засобами, нейродегенеративні й психіатричні розлади, і розлади шлунково-кишкового тракту. Також забезпечуються фармацевтичні композиції, які містять такі сполуки, і способи одержання таких сполук.The present invention provides 5-HTZ receptor antagonists of formula (I) :, (I) in particular 1- (1-methyl-1H-pyrazol-4-yl) -N - ((1R, 5S, 7S) -9-methyl-3 -oxa-9-azabicyclo [3.3.1] -nonan-7-yl) -1H-indole-3-carboxamide, for the treatment of diseases such as vomiting, pain, drug abuse, neurodegenerative and psychiatric disorders, and gastrointestinal disorders; of the intestinal tract. Also provided are pharmaceutical compositions containing such compounds and methods for preparing such compounds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261672709P | 2012-07-17 | 2012-07-17 | |
PCT/US2013/050746 WO2014014951A1 (en) | 2012-07-17 | 2013-07-16 | 5-ht3 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
UA113991C2 true UA113991C2 (en) | 2017-04-10 |
Family
ID=58530739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201500605A UA113991C2 (en) | 2012-07-17 | 2013-07-16 | 1- (1-methyl-1H-pyrazol-4-yl) -N - ((1R, 5S, 7S) -9-methyl-3-oxa-9-azabicyclo [3.3.1] -NONAN-7-yl) -1H-INDOL-3-CARBOXAMID AS A 5-HT3 RECEPTOR ANTAGONIST |
Country Status (2)
Country | Link |
---|---|
MA (1) | MA37836B1 (en) |
UA (1) | UA113991C2 (en) |
-
2013
- 2013-07-16 UA UAA201500605A patent/UA113991C2/en unknown
- 2013-07-16 MA MA37836A patent/MA37836B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA37836B1 (en) | 2018-10-31 |
MA37836A1 (en) | 2018-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201401150A1 (en) | AMINOINDOLYL SUBSTITUTED IMIDAZOLPYRIMIDINES AND THEIR APPLICATION AS MEDICINES | |
SI2875011T1 (en) | 5-ht3 receptor antagonists | |
MX351305B (en) | Mineralocorticoid receptor antagonists. | |
MY149731A (en) | Compounds | |
BR112012017123A2 (en) | n- (1h-indazol-4-yl) imidazo [1,2-a] pyridin-3-carboxamide compound as cfms inhibitors | |
EA201500298A1 (en) | ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES | |
TN2014000030A1 (en) | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators | |
MD20150023A2 (en) | Novel bicyclic pyridinones | |
EA201390969A1 (en) | GLUCAGON RECEPTOR MODULATORS | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
PH12014502586A1 (en) | Novel ring-substituted n-pyridinyl amides as kinase inhibitors | |
EA201390977A1 (en) | COMBINATION OF OPIOID RECEPTOR AGONIST AND OPIOID RECEPTOR ANTAGONIST FOR THE TREATMENT OF PARKINSON'S Disease | |
EA201270428A1 (en) | SUBSTITUTED N-PHENYL-1- (4-PYRIDINIL) -1H-PYRAZOL-3-AMINES | |
MX353209B (en) | D2 ANTAGONISTS, METHODS OF SYNTHESIS and METHODS OF USE. | |
BR112014001908A2 (en) | substituted heterocyclic aza derivatives | |
PH12014501195A1 (en) | Novel 2h-indazoles as ep2, receptor antagonists | |
UA117154C2 (en) | S1p3 antagonists | |
TN2016000061A1 (en) | Amide derivatives as lysophosphatidic acid receptor antagonists | |
MX2013006768A (en) | Glucagon receptor modulators. | |
WO2014014794A3 (en) | Mineralocorticoid receptor antagonists | |
PH12016501625A1 (en) | Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists | |
EA201201530A1 (en) | COMBINATION OF 4- {3- [CYC-HEXAGYDROCYCLOPENT [C] PYRROL-2- (1H) -IL] PROPOXY} BENZAMIDE AND NMDA-RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS, WHICH HAVE A VOLUME OF THE HYDROGECTOR AND THE ANTAGONIST | |
MX354852B (en) | Heterocyclyl compounds as histamine h3 receptor ligands. | |
MX2014000855A (en) | Quinolinyl glucagon receptor modulators. | |
UA113991C2 (en) | 1- (1-methyl-1H-pyrazol-4-yl) -N - ((1R, 5S, 7S) -9-methyl-3-oxa-9-azabicyclo [3.3.1] -NONAN-7-yl) -1H-INDOL-3-CARBOXAMID AS A 5-HT3 RECEPTOR ANTAGONIST |